IMPACT Medicom

Science EN ↓ 57 episodes

We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, video capsules, and podcasts at: https://www.impactmedicom.com.

Be sure to visit the podcast's website and support the creator: www.impactmedicom.com

Author

IMPACT Medicom

Episodes

Lung Cancer Screening: National 01.09.2021 25:07

Background Lung cancer is one of the most common cancers and is the leading cause of cancer death in Canada. (2020 Canadian Cancer Statistics) Survival from lung cancer is poor. Three-year net survival for lung cancer decreased from 71% among those diagnosed at stage 1 to 5% among those diagnosed at stage 4. Approximately half of all lung cancer cases in Canada are stage 4 at diagnosis. (2020 Can...

Precision Medicine in Oncology: Ep.4 Access to Genomic Profiling in Quebec 13.07.2021 33:43

In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss: · The initiatives developed by Colorectal Cancer Canada to help progress access to genomic profiling and precision medicine for all cancer patients · The patient’s perspective on education, access, and value of genomic profiling · Access to genomic profiling in Quebec · The val...

Treatment of Relapsed/Refractory Hodgkin's Lymphoma 09.07.2021 30:29

In this episode of our podcast, we are joined by a very special guest, Dr. John Kuruvilla, who is an Associate Professor of Medicine at the University of Toronto and a Clinical Investigator in the Division of Medical Oncology and Hematology at Princess Margaret Hospital in Toronto. We discuss: The current treatment of classical Hodgkin’s Lymphoma The use of checkpoint inhibitors for these patien...

Chronic Lymphocytic Leukemia (CLL): How do we Manage Patients During COVID-19? 28.10.2020 19:12

In this episode we discuss the management of CLL patients during the COVID-19 pandemic. Included is a discussion of: The initial treatment of patients with CLL during COVID-19 The use of BTK inhibitors vs FCR The use of intravenous or subcutaneous immunoglobulin Existing guidelines for the treatment of CLL during COVID-19 The virtual management of CLL patients Our guest: Dr. Pavic is a Medical On...

Virtual Patient Management during COVID-19: How can we best Manage Patients with Inflammatory Arthritis? 23.10.2020 25:00

On today’s podcast episode, we discuss the virtual management of patients with inflammatory arthritis. We are joined by: Dr. Janet Pope: Professor of Medicine in the Division of Rheumatology, Epidemiology and Biostatistics at the University of Western Ontario. Our episode includes a discussion of: The use of a virtual platform for managing patients with inflammatory arthritis. Which patients...

The Opioid Epidemic in Canada: What Can We Do? 22.10.2020 28:19

In this episode, we discuss the opioid epidemic in Canada and the use of naloxone, a life-saving drug that is used to prevent death from opioid overdose, with pharmacists: Dr. Ross Tsuyuki and Mark Barnes. Dr. Ross Tsuyuki - professor and chair of the Department of Pharmacology in the Faculty of Medicine and Dentistry at the University of Alberta. Mark Barnes - owner of Respect Rx Pharmacies i...

COVID-19: Playing Sports Safely with Dr. Ray Deonandan 14.10.2020 26:10

Dr. Ray Deonandan is a Canadian epidemiologist, assistant director, and associate professor at the University of Ottawa. In this episode, we discuss how we can exercise safely during the COVID-19 epidemic as the cold weather approaches. The importance of exercise for physical and mental health is discussed as well as tips for reducing the chance of COVID-19 transmission while exercising. We discu...